TRIAL DETAIL

Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan

Drug:
Trial Name:
Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan
NCT#:
Conditions:
Solid Tumors
Status:
Completed
Phase:
1
Start Date 07/01/2009
Age of Trial (yrs) 12.4
Treatment Phase:
Gleevec-resistant
Drug Category:
IGF1R inhibitor
Strategy:
Block related tumor signal paths
Trial Type:
GIST not specified. GIST patient enrollment unknown.
Other Protocol IDs:
CA191-003
Sponsor:
Bristol-Myers Squibb
Patient Contact:
Clinical.Trials@bms.com
Contact email:
Contact Phone:
Randomized:
IV or Oral:
Oral
Trial Notes:

Trial Links

Trial Results

Drug Information

Trial Sites

Name
Address
City
State
Zip
Country
Tokyo
104-0045
Japan